Literature DB >> 14511641

The cyclin-dependent kinase 11(p46) isoform interacts with RanBPM.

Monika Mikolajczyk1, Jiaqi Shi, Richard R Vaillancourt, Nancy A Sachs, Mark Nelson.   

Abstract

We identified Ran-binding protein (RanBPM) as an interacting partner of the caspase-processed C-terminal domain of cyclin-dependent kinase 11 (CDK11(p46)) by using the yeast two-hybrid system. CDK11(p110) protein kinases are members of the cyclin-dependent kinase superfamily. During staurosporine-, Fas-, and tumor necrosis factor alpha-induced apoptosis caspase-processed activated CDK11(p46) is generated from larger CDK11(p110) isoforms. CDK11(p46) promotes apoptosis when it is ectopically expressed in human cells. However, the mechanism of signal transduction through CDK11(p46) is still unclear. In this study, we demonstrate that CDK11(p46) directly interacts with RanBPM in vitro and in human cells. RanBPM contains a conserved SPRY (repeats in splA and Ryr) domain and is localized both in the nucleus and cytoplasm. The SPRY domain of RanBPM is responsible for the association between CDK11(p46) and RanBPM. Furthermore, we show that CDK11(46) phosphorylates RanBPM.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14511641     DOI: 10.1016/j.bbrc.2003.08.116

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  15 in total

1.  The Ran-binding protein RanBPM can depress the NF-κB pathway by interacting with TRAF6.

Authors:  Lan Wang; Chengbo Fu; Yingbin Cui; Yunfei Xie; Yuhe Yuan; Xin Wang; Hong Chen; Bing-Ren Huang
Journal:  Mol Cell Biochem       Date:  2011-07-30       Impact factor: 3.396

2.  Death-signal-induced relocalization of cyclin-dependent kinase 11 to mitochondria.

Authors:  Yongmei Feng; Maria E Ariza; Anne-Christine Goulet; Jiaqi Shi; Mark A Nelson
Journal:  Biochem J       Date:  2005-11-15       Impact factor: 3.857

3.  Regulation of mu opioid receptor internalization by the scaffold protein RanBPM.

Authors:  Jeffery N Talbot; Donald A Skifter; Elisabetta Bianchi; Daniel T Monaghan; Myron L Toews; L Charles Murrin
Journal:  Neurosci Lett       Date:  2009-09-27       Impact factor: 3.046

4.  RanBPM associates with CD39 and modulates ecto-nucleotidase activity.

Authors:  Yan Wu; Xiaofeng Sun; Elzbieta Kaczmarek; Karen M Dwyer; Elisabetta Bianchi; Anny Usheva; Simon C Robson
Journal:  Biochem J       Date:  2006-05-15       Impact factor: 3.857

5.  RanBPM regulates the progression of neuronal precursors through M-phase at the surface of the neocortical ventricular zone.

Authors:  Yoonjeung Chang; Murugan Paramasivam; Matthew J Girgenti; Randall S Walikonis; Elisabetta Bianchi; Joseph J LoTurco
Journal:  Dev Neurobiol       Date:  2010-01       Impact factor: 3.964

6.  RanBPM expression regulates transcriptional pathways involved in development and tumorigenesis.

Authors:  Elnaz Atabakhsh; Jean H Wang; Xu Wang; David E Carter; Caroline Schild-Poulter
Journal:  Am J Cancer Res       Date:  2012-08-20       Impact factor: 6.166

Review 7.  Inhibitors of cyclin-dependent kinases as cancer therapeutics.

Authors:  Steven R Whittaker; Aurélie Mallinger; Paul Workman; Paul A Clarke
Journal:  Pharmacol Ther       Date:  2017-02-05       Impact factor: 12.310

8.  Aggresome formation is regulated by RanBPM through an interaction with HDAC6.

Authors:  Louisa M Salemi; Ahmad W Almawi; Karen J Lefebvre; Caroline Schild-Poulter
Journal:  Biol Open       Date:  2014-05-02       Impact factor: 2.422

9.  RanBPM is an inhibitor of ERK signaling.

Authors:  Elnaz Atabakhsh; Caroline Schild-Poulter
Journal:  PLoS One       Date:  2012-10-31       Impact factor: 3.240

10.  Neuronal expression of muskelin in the rodent central nervous system.

Authors:  Nadia Tagnaouti; Sven Loebrich; Frank Heisler; Yvonne Pechmann; Susanne Fehr; Adèle De Arcangelis; Elisabeth Georges-Labouesse; Josephine C Adams; Matthias Kneussel
Journal:  BMC Neurosci       Date:  2007-05-02       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.